Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Clinical trial NCT00494871 · COMPLETED

Trial details

NCT number: NCT00494871
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2007-06-01
Primary completion: 2009-12-01
Enrollment: 1280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.